Topic List : Neuroscience
Brain abnormalities in PANS
MRI brain scans show subtle changes consistent with inflammation in a severe childhood disease in which the immune system is thought to attack the brain, Stanford researchers found.
Potential autism biomarker found in babies
Cerebrospinal fluid levels of a hormone called vasopressin were lower in babies who went on to develop autism than in those who did not, a study found.
Alzheimer’s countered by gene variant
Stanford Medicine researchers have found a gene variant that protects carriers of another gene variant, ApoE4, from developing Alzheimer’s disease — the first demonstration of that beneficial effect.
Exercise rejuvenates stem cells of old mice
The researchers also identified a molecular pathway involved in turning back the clock on the cells. Drugs that could manipulate the pathway might be an effective substitute for exercise, they suggest.
AA best for alcohol abstinence, study finds
A Stanford researcher and two collaborators conducted an extensive review of Alcoholics Anonymous studies and found that the fellowship helps more people achieve sobriety than therapy does.
Brain waves can determine drug response
Researchers used electroencephalography and artificial intelligence to identify individuals who would likely respond to sertraline, the antidepressant marketed as Zoloft.
Proteins in blood indicate people’s age
Protein levels in people’s blood can predict their age, a Stanford study has found. The study also found that aging isn’t a smoothly continuous process.
Epilepsy-associated cognitive disruption
Transient bursts of high-frequency electrical activity in epileptic brain tissue can impair cognition even when no seizure is occurring, Stanford scientists have found.
Cause of deadly neurological disease found
A drug may help children with Pelizaeus-Merzbacher disease, a deadly neurological disorder, according to a study by researchers at Stanford, UCSF and Cambridge.
$4.75 million for high-risk, high-reward research
Jin Hyung Lee will receive $3.5 million to study the use of innovative technology to analyze brain circuitry, and Corey Keller will receive $1.25 million to fund work into brain stimulation treatments for mental illness.